New Hopes for Drugs against COVID-19 Come from the Sea

doi:10.3390/md19020104

Editorial

. 2021 Feb 11;19(2):104.

doi: 10.3390/md19020104.

New Hopes for Drugs against COVID-19 Come from the Sea

Orazio Taglialatela-Scafati¹

Affiliations

PMID: 33670191
PMCID: PMC7916939
DOI: 10.3390/md19020104

Editorial

New Hopes for Drugs against COVID-19 Come from the Sea

Orazio Taglialatela-Scafati. Mar Drugs. 2021.

. 2021 Feb 11;19(2):104.

doi: 10.3390/md19020104.

Author

Orazio Taglialatela-Scafati¹

Affiliation

¹ Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Via D. Montesano 49, I-80131 Naples, Italy.

PMID: 33670191
PMCID: PMC7916939
DOI: 10.3390/md19020104

Abstract

The latest chapter of the historic battle of humans against pathogenic microbes is the severe acute respiratory syndrome (SARS)-like coronavirus-2 (SARS-CoV-2), responsible for COVID-19, a respiratory disease declared a global pandemic by the WHO on March 11, 2020 [...].

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

Figures

**Figure 1**
The chemical structures of gallinamide A (1) and plitidepsin (2).

See this image and copyright information in PMC

Cited by

The Anti-Viral Applications of Marine Resources for COVID-19 Treatment: An Overview.
Geahchan S, Ehrlich H, Rahman MA. Geahchan S, et al. Mar Drugs. 2021 Jul 23;19(8):409. doi: 10.3390/md19080409. Mar Drugs. 2021. PMID: 34436248 Free PMC article. Review.
The Identification of Peptide Inhibitors of the Coronavirus 3CL Protease from a Fucus ceranoides L. Hydroalcoholic Extract Using a Ligand-Fishing Strategy.
Duarte Filho LAMS, Yanaguibashi Leal CE, Bodet PE, Beserra de Alencar Filho E, Almeida JRGDS, Porta Zapata M, Achour O, Groult H, Gouveia Veloso CA, Viegas Júnior C, Bourgougnon N, Picot L. Duarte Filho LAMS, et al. Mar Drugs. 2024 May 27;22(6):244. doi: 10.3390/md22060244. Mar Drugs. 2024. PMID: 38921555 Free PMC article.
The vital role of animal, marine, and microbial natural products against COVID-19.
Alqathama AA, Ahmad R, Alsaedi RB, Alghamdi RA, Abkar EH, Alrehaly RH, Abdalla AN. Alqathama AA, et al. Pharm Biol. 2022 Dec;60(1):509-524. doi: 10.1080/13880209.2022.2039215. Pharm Biol. 2022. PMID: 35234563 Free PMC article. Review.
Paralemnolins X and Y, New Antimicrobial Sesquiterpenoids from the Soft Coral Paralemnalia thyrsoide.
Elshamy AI, Mohamed TA, Elkady EM, Saleh IA, El-Beih AA, Alhammady MA, Ohta S, Umeyama A, Paré PW, Hegazy MF. Elshamy AI, et al. Antibiotics (Basel). 2021 Sep 24;10(10):1158. doi: 10.3390/antibiotics10101158. Antibiotics (Basel). 2021. PMID: 34680740 Free PMC article.
Antiproliferative Illudalane Sesquiterpenes from the Marine Sediment Ascomycete Aspergillus oryzae.
Orfali R, Perveen S, Khan MF, Ahmed AF, Wadaan MA, Al-Taweel AM, Alqahtani AS, Nasr FA, Tabassum S, Luciano P, Chianese G, Sheu JH, Taglialatela-Scafati O. Orfali R, et al. Mar Drugs. 2021 Jun 10;19(6):333. doi: 10.3390/md19060333. Mar Drugs. 2021. PMID: 34200759 Free PMC article.

See all "Cited by" articles

References

1. WHO Coronavirus Disease (COVID-19) Dashboard. [(accessed on 5 February 2021)]; Available online: https://covid19.who.int/
1. FDA Approves First Treatment for COVID-19. [(accessed on 5 February 2021)]; Available online: https://www.fda.gov/news-events/press-announcements/fda-approves-first-t....
1. Jang Y., Shin H., Lee M.K., Kwon O.S., Shin J.S., Kim Y., Kim C.W., Lee H.-R., Kim M. Antiviral activity of lambda-carrageenan against influenza viruses and severe acute respiratory syndrome coronavirus 2. Sci. Rep. 2021;11:821. doi: 10.1038/s41598-020-80896-9. - DOI - PMC - PubMed
1. Fitton J.H., Park A.Y., Karpiniec S.S., Stringer D.N. Fucoidan and lung function: Value in viral infection. Mar. Drugs. 2021;19:4. doi: 10.3390/md19010004. - DOI - PMC - PubMed
1. Zahran E.M., Albohy A., Khalil A., Ibrahim A.H., Ahmed H.A., El-Hossary E.M., Bringmann G., Abdelmohsen U.R. Bioactivity potential of marine natural products from Scleractinia-associated microbes and in silico anti-SARS-COV-2 evaluation. Mar. Drugs. 2020;18:645. doi: 10.3390/md18120645. - DOI - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Miscellaneous
- NCI CPTAC Assay Portal

[1] WHO Coronavirus Disease (COVID-19) Dashboard. [(accessed on 5 February 2021)]; Available online: https://covid19.who.int/

[2] WHO Coronavirus Disease (COVID-19) Dashboard. [(accessed on 5 February 2021)]; Available online: https://covid19.who.int/

[3] FDA Approves First Treatment for COVID-19. [(accessed on 5 February 2021)]; Available online: https://www.fda.gov/news-events/press-announcements/fda-approves-first-t....

[4] FDA Approves First Treatment for COVID-19. [(accessed on 5 February 2021)]; Available online: https://www.fda.gov/news-events/press-announcements/fda-approves-first-t....

[5] Jang Y., Shin H., Lee M.K., Kwon O.S., Shin J.S., Kim Y., Kim C.W., Lee H.-R., Kim M. Antiviral activity of lambda-carrageenan against influenza viruses and severe acute respiratory syndrome coronavirus 2. Sci. Rep. 2021;11:821. doi: 10.1038/s41598-020-80896-9. - DOI - PMC - PubMed

[6] Jang Y., Shin H., Lee M.K., Kwon O.S., Shin J.S., Kim Y., Kim C.W., Lee H.-R., Kim M. Antiviral activity of lambda-carrageenan against influenza viruses and severe acute respiratory syndrome coronavirus 2. Sci. Rep. 2021;11:821. doi: 10.1038/s41598-020-80896-9. - DOI - PMC - PubMed

[7] Fitton J.H., Park A.Y., Karpiniec S.S., Stringer D.N. Fucoidan and lung function: Value in viral infection. Mar. Drugs. 2021;19:4. doi: 10.3390/md19010004. - DOI - PMC - PubMed

[8] Fitton J.H., Park A.Y., Karpiniec S.S., Stringer D.N. Fucoidan and lung function: Value in viral infection. Mar. Drugs. 2021;19:4. doi: 10.3390/md19010004. - DOI - PMC - PubMed

[9] Zahran E.M., Albohy A., Khalil A., Ibrahim A.H., Ahmed H.A., El-Hossary E.M., Bringmann G., Abdelmohsen U.R. Bioactivity potential of marine natural products from Scleractinia-associated microbes and in silico anti-SARS-COV-2 evaluation. Mar. Drugs. 2020;18:645. doi: 10.3390/md18120645. - DOI - PMC - PubMed

[10] Zahran E.M., Albohy A., Khalil A., Ibrahim A.H., Ahmed H.A., El-Hossary E.M., Bringmann G., Abdelmohsen U.R. Bioactivity potential of marine natural products from Scleractinia-associated microbes and in silico anti-SARS-COV-2 evaluation. Mar. Drugs. 2020;18:645. doi: 10.3390/md18120645. - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

New Hopes for Drugs against COVID-19 Come from the Sea

Affiliation

New Hopes for Drugs against COVID-19 Come from the Sea

Author

Affiliation

Abstract

Conflict of interest statement

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Miscellaneous

Abstract

Conflict of interest statement

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Miscellaneous